4.3 Article

Single-center, assessor-blind study to evaluate the efficacy and safety of DA-5520 topical gel in patients with acne scars: A pilot study

期刊

JOURNAL OF COSMETIC DERMATOLOGY
卷 21, 期 9, 页码 3888-3895

出版社

WILEY
DOI: 10.1111/jocd.14693

关键词

acne scars; acne vulgaris; allantoin; dexpanthenol; heparin sodium

资金

  1. Dong-A Pharm

向作者/读者索取更多资源

This study evaluated the safety and efficacy of a topical gel, DA-5520, for the treatment of different types of acne scars. The results showed that DA-5520, when combined with laser resurfacing or used alone, improved acne scars clinically, without any associated adverse reactions.
Background Unlike various topical treatment options for acne vulgaris, options for acne scars mostly involve invasive interventions. So far, only a few clinical trials have investigated the effects of topical treatment for acne scars. Objectives We evaluated the safety and efficacy of DA-5520, a recently developed topical gel for the treatment of different types of acne scars. Methods A 12-week prospective, randomized, active-controlled, evaluator-blind, single-center study involving 36 participants with acne scars was performed. Participants were randomized into four different groups at a 1:1:1:1 ratio: laser resurfacing with DA-5520 application (test 1); laser resurfacing without DA-5520 application (control 1); comedone extraction with DA-5520 application (test 2); and comedone extraction without DA-5520 application (control 2). For 12 weeks, participants in the two test groups applied DA-5520 twice daily, while participants in the control groups applied moisturizers alone. Participants in the test 1 and control 1 groups received a single session of laser resurfacing at visit 1 (week 0). All participants were followed up at 1, 4, 8, and 12 weeks, and objective scar evaluation using the echelle d'evaluation clinique des cicatrices d'acne (ECCA) score was performed at each visit. Results Clinical improvement of acne scars, confirmed by the ECCA grading scale (1 for atrophic scar and 2 for hypertrophic scar), was observed after using DA-5520 when combined with laser resurfacing or individually, and no associated adverse reactions were noted. Conclusions Preliminary results of this study revealed that DA-5520 may be a promising new formulation for treating all type of acne scars.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据